期刊文献+

原发性高血压肾病患者尿微量白蛋白和血清胱抑素C水平检测的临床意义 被引量:10

Clinical significance of determination of urine microalbumin and serum cystatin C levels in patients with primary hypertension nephropathy
下载PDF
导出
摘要 目的:探讨原发性高血压肾病患者尿微量白蛋白和血清胱抑素C水平的变化及意义。方法:应用免疫比浊法和ELISA法对36例原发性高血压肾病患者进行尿微量白蛋白和血清胱抑素C水平测定,并与30例正常健康人作比较。结果:原发性高血压肾病患者尿微量白蛋白和血清胱抑素C水平均明显高于正常人组(P<0.01),且两者呈明显正相关(r=0.5921 P<0.01)。结论:检测原发性高血压肾病患者尿微量白蛋白和血清胱抑素C水平的变化对了解病情和观察愈后均具有重要的临床价值。 Objective:To explore the clinical significance of determination of urine microalbumin and serum cystatin C levels in the patients with primary hypertension nephropathy.Methods:Urine microalbumin levels (with immunoturbidimetry)and serum cystatin C levels (with ELISA) were determined in 36 patients with primary hypertension nephropathy and 30 controls.Results:Urine microalbumin and serum cystatin C levels in the patients with primary hypertension nephropathy were significantly higher than those in controls (P〈0.01). Urine mieroalbumin and serum cystatin C levels were mutually positively correlated (r=0.5921 P〈0.01).Conclusion:Urine microalbumin and serum cystatin C levels were closely related to the diseases process of primary hypertension nephropathy and have important prognostic values.
作者 王晓燕
机构地区 灌云县板浦医院
出处 《现代医药卫生》 2010年第7期1007-1008,共2页 Journal of Modern Medicine & Health
关键词 原发性高血压肾病 尿微量白蛋白 胱抑素C Primary hypertension nephropathy Urine mieroalbumin Cystatin C
  • 相关文献

参考文献3

二级参考文献26

  • 1林青,福建医科大学学报,1998年,32卷,50页
  • 2魏有仁,生物化学与生物物理进展,1995年,22卷,169页
  • 3Wu J T,J Clin Lab Anal,1993年,7卷,252页
  • 4于宏,实用高血压学,1993年,878页
  • 5Kos J, Stabuc B, Cimerman N, et al. Clin Chem, 1998 ;44:2556 - 7
  • 6Coll EA,Tavern C,Prevot D,et al.J Immunoassay,1992;13:47-60
  • 7Young DS. Effects of Drugs on Clinical Laboratory Tests. American Association of Clinical Chemistry Press,Washington, DC, 1990
  • 8H:Lbrands LH,Artz MA,Wetzds JEH.Lancet,1992;340:1326- 1329
  • 9Fuller NJ,Elia M. Clin Chim Acta, 1988; 175:199 - 210
  • 10Campens D, Buntindx F. Int J Technol Assess Health Care, 1997; 13: 343-56

共引文献343

同被引文献72

  • 1刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 2Chew JS,Saleem M,Florkowski CM,et al.Cystatin C-a paradigm of evidence based Laboratory medicine[J].Clin Biochem Rev,2008,29(2):47-62.
  • 3Sato H,Kuroda T,Tanabe N,et al.Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney diseaes in patient with rheumatoid and secondary amloidosis[J].Scand J Rheunatol,2010,39(1):33-37.
  • 4朱明德,石应康.临床医学概要[M].3版.北京:人民卫生出版社,2009:551-553.
  • 5Chew JS, Saleem M, Florkowski CM, et al. Cystatin C-a paradigm of evidence based Laboratory medicine [J]. Clin Biochem Rev, 2008, 29(2): 47-62.
  • 6Sato H, Kuroda T, Tanabe N, et al. Cystatin C is a sensitive marker for dete-Cting a reduced glomerular filtration rate when assessing chronic kidney dis-Eaes in patient with rheumatoid and secondary amloidosis [J]. Scand J Rheunatol, 2010, 39( 1 ): 33-37.
  • 7章文莉,苏津自.胰激肽原酶对自发性高血压大鼠肾损害的保护作用[J].中华高血压杂志,2007,15(10):844-848. 被引量:1
  • 8Ma YC, Li Z, Chen JH, et al. Modified glomerular filtration rate estimating equation for chinese patients with chronic kidney disease [ J ]. J Am Soc Nephro1,2006 , 17:2937-44.
  • 9孙宁玲,王鸿懿,喜杨,等.中国高血压患者微量白蛋白尿检出的分析[C].大连:中华医学会第11次心血管病学术会议论文摘要集,2009.
  • 10Tarif N,Alwakeel JS,Mitwalli AH,et al.Serum eystatin C as a marker of renal function in patients with acute renal failure [J]. Saudi ,1 Kidney Dis Transpl,2008,19(6):918-923.

引证文献10

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部